Scholarlink

Background <p>Diabetes mellitus is a metabolic disease that affects many systems and is marked by extensive vascular problems. One large microvascular bed that may be vulnerable to diabetic microangiopathy is the pulmonary alveolar–capillary network. This study aimed to assess pulmonary function in patients with type 2 diabetes mellitus (T2DM) and to examine its association with glycaemic control and disease duration.</p> Methods <p>This cross-sectional observational study was conducted at Ain Shams University Hospitals between February 2025 and February 2026. A total of 150 participants were enrolled, including 50 patients with controlled T2DM (HbA1c ≤ 7%), 50 patients with uncontrolled T2DM (HbA1c &gt; 7%), and 50 age-matched healthy controls. Participants were recruited from both outpatient and inpatient settings. Data collection included fasting blood glucose, 2-hour postprandial glucose, HbA1c levels, and pulmonary function tests (PFTs).</p> Results <p>Baseline demographic characteristics, including age, sex, and body mass index, were comparable among groups. Pulmonary function parameters including FEV1, FVC, FEF25, FEF50, and FEF25–75 were significantly reduced in the uncontrolled T2DM group. Although FEV1/FVC showed an overall significant difference among groups, post-hoc analysis demonstrated that this was mainly driven by differences between diabetic groups and healthy controls. HbA1c showed weak-to-moderate negative correlations with several spirometric indices, particularly FEV1, FVC, FEF25, and FEF50, while longer diabetes duration was also associated with reduced pulmonary function. Multiple regression analysis identified HbA1c as the strongest independent predictor of pulmonary function decline.</p> Conclusion <p>Uncontrolled T2DM was associated with lower spirometric parameters in this study. However, because comprehensive pulmonary function testing including lung volumes and diffusion capacity was not performed, the nature of the ventilatory abnormality cannot be definitively determined. These findings may support a potential role for pulmonary function assessment in selected patients with T2DM and warrant further longitudinal evaluation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessment of pulmonary function test in type 2 diabetes mellitus and its relation to glycaemic control and duration of disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月25日

查看全文
  • Ahmed Mahmoud Mohamed Galal,
  • Yvette Ezzat Eid Iskandar,
  • Riham Hazem Raafat

摘要

Background

Diabetes mellitus is a metabolic disease that affects many systems and is marked by extensive vascular problems. One large microvascular bed that may be vulnerable to diabetic microangiopathy is the pulmonary alveolar–capillary network. This study aimed to assess pulmonary function in patients with type 2 diabetes mellitus (T2DM) and to examine its association with glycaemic control and disease duration.

Methods

This cross-sectional observational study was conducted at Ain Shams University Hospitals between February 2025 and February 2026. A total of 150 participants were enrolled, including 50 patients with controlled T2DM (HbA1c ≤ 7%), 50 patients with uncontrolled T2DM (HbA1c > 7%), and 50 age-matched healthy controls. Participants were recruited from both outpatient and inpatient settings. Data collection included fasting blood glucose, 2-hour postprandial glucose, HbA1c levels, and pulmonary function tests (PFTs).

Results

Baseline demographic characteristics, including age, sex, and body mass index, were comparable among groups. Pulmonary function parameters including FEV1, FVC, FEF25, FEF50, and FEF25–75 were significantly reduced in the uncontrolled T2DM group. Although FEV1/FVC showed an overall significant difference among groups, post-hoc analysis demonstrated that this was mainly driven by differences between diabetic groups and healthy controls. HbA1c showed weak-to-moderate negative correlations with several spirometric indices, particularly FEV1, FVC, FEF25, and FEF50, while longer diabetes duration was also associated with reduced pulmonary function. Multiple regression analysis identified HbA1c as the strongest independent predictor of pulmonary function decline.

Conclusion

Uncontrolled T2DM was associated with lower spirometric parameters in this study. However, because comprehensive pulmonary function testing including lung volumes and diffusion capacity was not performed, the nature of the ventilatory abnormality cannot be definitively determined. These findings may support a potential role for pulmonary function assessment in selected patients with T2DM and warrant further longitudinal evaluation.